(Q24305950)

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

To die or not to die: how does p53 decide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

p53: a heavily dictated dictator of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

DNA microarrays identification of primary and secondary target genes regulated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

p53 has a direct apoptogenic role at the mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Mitochondrially targeted p53 has tumor suppressor activities in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Ser392 phosphorylation regulates the oncogenic function of mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

p53 regulation of G(2) checkpoint is retinoblastoma protein dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Initiation factor modifications in the preapoptotic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

eIF2 and the control of cell physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

The p53 response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

7 January 2021

p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

7 January 2021

p53-induced inhibition of protein synthesis is independent of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

7 January 2021

Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.02.030

7 January 2021